Kadcyla approved for late-stage breast cancer treatment

12:21 PM, Feb 22, 2013   |    comments
  • Share
  • Print
  • - A A A +

(CNN/KAKE) - Patients with a specific type of late-stage breast cancer may have some hope.

The FDA just approved a new drug called Kadcyla. It's a treatment therapy for women with HER2-positive breast cancer.

Kadcyla is a combination of two drugs, one of which is a powerful chemotherapy drug.

It should be available to patients within two weeks.


Most Watched Videos